Julia Y. Ljubimova
Professor and Director of Nanomedicine Research Center
Department of Neurosurgery
Cedars-Sinai Medical Center
USA
Nanomedicine Research Center
USA
Biography
Ljubimova is a Professor and Director of Nanomedicine Research Center at the Department of Neurosurgery at Cedars-Sinai Medical Center. She works in clinical and basic cancer research in her entire career. The major interest is the differential cancer gene expression as a tool for finding novel/early markers of cancer development, and for working out new nanomedicine drugs against these tumor targets for treatment and/or imaging. One of the novel markers, the structural tumor vessel wall protein laminin-411, is currently in a clinical trial as a prognostic and diagnostic marker for human glial tumor progression. These discoveries led to the development of new technologies for drug delivery and engineering of the new class of anti-cancer nanomedicine drugs. Currently her research is supported by three NIH/NCI, private and industry grants. She is the author of over 70 publications, reviews and book chapters as well as an inventor on nine patents and patent applications.
Research Interest
Primary research interests involve methods to block human glioma growth, brain tumor prevention treatments and the effects of air pollution on the brain.